Stock Comparison

MRNA vs VRTX

Moderna Inc and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

MRNA

Moderna Inc

Healthcare

VRTX

Vertex Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$25.14B

$123.94B

P/E (TTM)

—

28.5

Forward P/E

24.5

25.7

Price/Sales

11.3

9.9

Price/Book

3.7

6.1

EV/EBITDA

4.9

23.2

Dividend Yield

—

Profitability

Net Margin

-141.43%

35.40%

Operating Margin

-149.01%

38.97%

Return on Equity

-39.00%

23.50%

Return on Assets

-13.30%

11.90%

Growth (YoY)

Revenue Growth

2.10%

12.50%

Earnings Growth

-85.10%

8.00%

Price & Risk

Beta

0.9

0.3

52-Week High

$81.80

$529.65

52-Week Low

$22.36

$376.62

Analyst Target

$50.84

$559.28

Compare MRNA and VRTX your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.